We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

By LabMedica International staff writers
Posted on 17 Mar 2015
Print article
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).
Image: Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).
Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead to cancer and other diseases.

The new study was carried out by researchers from The Scripps Research Institute (TSRI; La Jolla, CA, USA). “These proteins play an important role in the response to DNA damage,” said senior author Katja Lamia, “Researchers might eventually harness that knowledge for pharmaceutical targeting.”

People with unusual sleep schedules, such as flight attendants or rotating night-shift nurses, are at higher risk for certain health problems. The human body senses light and adjusts rhythms to the day-night cycle via the circadian clock. Hunger and sleepiness, for example, are strongly influenced by this clock. “When you have a deregulation of your circadian clock, you’re more prone to develop some kind of pathology, like diabetes, cancer, or heart disease,” said co-first author and research associate Anne-Laure Huber.

To investigated a possible cause of these health disparities, the team focused on the role of the circadian transcriptional repressors cryptochrome 1 (Cry1) and 2 (Cry2), which evolved from bacterial light-activated DNA repair enzymes. While cryptochromes are no longer light-activated, they do hold to a daily-regulated schedule, and stability of Cry1 and Cry2 is critical for circadian clock function. In humans, cryptochromes are essential for regulating blood sugar levels and protein production on a day-night cycle, but no longer have a direct role in DNA repair activity.

The study was initiated with proteomic screening to fish out proteins that could bind Cry1 or Cry2. The team found that Cry1 could bind Hausp, which has a known role in regulating the anti-cancer protein p53. The screening also showed that Hausp binds Cry2, but less strongly, suggesting that the nearly identical Cry1 and Cry2 have different roles related to DNA repair. “Most of the time people study them as redundant proteins, but we show that they have distinct functions in this DNA-repair pathway,” said Dr. Lamia.

Genetic expression experiments then showed that Hausp stabilizes Cry1, which helps prevent potential errors in DNA transcription that could occur upon DNA exposure to radiation. “This is very cool,” said co-first author and graduate student Stephanie Papp, “These proteins can sense that something is wrong in the cells.” When the researchers blocked Cry2 production, the cells no longer activated p21, a protein that stops mutant cells from dividing. “This could suggest that cells without Cry2 would be more susceptible to cancer,” said Dr. Lamia.

These and additional findings of the study showed that while Cry1/2 no longer directly repair DNA, they have adapted to provide an indirect role in the repair process, protecting genomic integrity via coordinated transcriptional regulation. This new link between circadian clock proteins and DNA repair is a clue to how disrupting day-night cycles could harm health.

The study, by Papp SJ, Huber AL, et al, was published March 10, 2015, in the journal eLife.

Related Links:

The Scripps Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more